FORMULIERUNG MIT CERALASERTIB

Patent europeic · EP4312993 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4312993
Numer da la dumonda
EP22717111
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-03-2022
Publitgà
07-02-2024
Concedì
08-10-2025
La protecziun finescha il pli tard
20-03-2042
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61K 9/20 (2006.01)
A61K 31/5377 (2006.01)
A61P 35/00 (2006.01)
Prioritad
WO PCT/CN2021/081978 22.03.2021
Dumonda PCT
PCT/EP2022/057305 21.03.2022
Publicaziun PCT
WO2022/200251 29.09.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-08-2026

    Midada

    Published in Swissreg on 19.08.2026

  2. 01-04-2026

    Next annual fee due on

    Next annual fee due on
    31.03.2026 → 31.03.2027

    Published in Swissreg on 01.04.2026

  3. 08-01-2026

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 08.01.2026

  4. 08-10-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.10.2025

Partidas

Inventur

SIMPSON, David Bradley Brook

Cambridge Cambridgeshire CB2 0AA, GB

REN, Haixia

Shanghai, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.